RO-104 is designed to address all three clinically validated dominant angiogenic pathways (VEGF-A, VEGF-C, Ang-2) implicated in retinal vascular disease progression, including neovascular AMD and ...
21h
Altheria Stokes was diagnosed with type 2 diabetes in 1998. Since then, she's been managing it by living a healthy lifestyle ...
“The technology is now changing people’s lives,” Shen said.
3hon MSN
In 2025 the Oura Ring will integrate with Dexcom glucose sensors Dexcom data will sit alongside other health points within ...
Boehringer Ingelheim, a leading research-driven biopharmaceutical company, has been lifted to 8th place in the 2024 Access to Medicine Index (ATMI), up from 13th in 2022. This improvement reflects the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback